Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 061225/0188 | |
| Pages: | 4 |
| | Recorded: | 09/27/2022 | | |
| Attorney Dkt #: | 112171-0054 (70030US00) |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17776873
|
Filing Dt:
|
05/13/2022
|
|
Publication #:
|
|
Pub Dt:
|
11/09/2023
| | | | |
|
Title:
|
PYRROLOPYRIMIDINE COMPOUND AS BTK INHIBITOR AND USE THEREOF
|
|
|
Assignee
|
|
|
|
|
| BUILDING 7 (6 FLOORS), HEDA PHARMACEUTICAL VALLEY |
| HANGZHOU PHARMA. PORT, ZHEJIANG PROVINCE, CHINA |
|
|
Correspondence name and address
|
| |
MCDERMOTT WILL & EMERY
|
| |
200 CLARENDON STREET, 58TH FLOOR
|
| |
BOSTON, MA 02116-5021
|
Search Results as of:
06/14/2024 06:12 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
